DalsnaFinance › IPOs › Aquestive Therapeutics Inc › IPO
Aquestive Therapeutics, Inc. completed its initial public offering on NASDAQ on July 25, 2018, pricing at $15.00 a share.
| Ticker | AQST |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | July 25, 2018 |
| Offering price | $15.00 |
| Shares offered | 4,500,000 |
| Total raised | $68M |
Aquestive Therapeutics, Inc. sold 4,500,000 shares at $15.00 each on NASDAQ. Multiplied out, that is $67.5 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $68 million total recorded for the deal.
Aquestive Therapeutics, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Aquestive Therapeutics, Inc.. This page is general information, not investment advice.